Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990-2001

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 74-81

  Koivisto Korander, Riitta ^a   Butzow, Ralf ^a   Koivisto, Anna Maija ^b   Leminen, Arto ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Carcinosarcoma; Endometrial stromal sarcoma; Leiomyosarcoma; Uterine sarcoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MIFEPRISTONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR VOLUME; UNIVERSITY HOSPITAL; UTERUS MYOMA; UTERUS SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 52049107071     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.002     Document Type: Article

References (37)

1. Lurain J., and Piver M. Uterine sarcomas: clinical features and management. In: Coppleson M. (Ed). Gynecological Oncology (1992), Churchill Livingstone, Edinburgh; London; Melbourne; New York 827-842
2. Nordal R.R., and Thoresen S.O. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 33 6 (May 1997) 907-911
3. Ronnett B., Zaino R., Ellenson L., et al. Endometrial carcinoma. In: Kurman R.J. (Ed). Blaustein's Pathology of the Female Genital Tract. 5th ed. (2002), Springer-Verlag, New York 460-501
4. Chauveinc L., Deniaud E., Plancher C., Sastre X., Amsani F., de la Rochefordiere A., et al. Uterine sarcomas: the Curie Institute experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 72 2 (Feb 1999) 232-237
5. Pautier P., Genestie C., Rey A., Morice P., Roche B., Lhomme C., et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88 6 (Mar 15 2000) 1425-1431
6. El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J., et al. Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25 3 (Jun 2002) 256-260
7. Brooks S.E., Zhan M., Cote T., and Baquet C.R. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93 1 (Apr 2004) 204-208
8. Livi L., Paiar F., Meldolesi E., Simontacchi G., Amunni G., Barca R., et al. Treatment of uterine sarcoma at the University of Florence from 1980-2001. Tumori 91 2 (Mar-Apr 2005) 139-143
9. Benoit L., Arnould L., Cheynel N., Goui S., Collin F., Fraisse J., et al. The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 31 4 (May 2005) 434-442
10. Kokawa K., Nishiyama K., Ikeuchi M., Ihara Y., Akamatsu N., Enomoto T., et al. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer 16 3 (May-Jun 2006) 1358-1363
11. Sagae S., Yamashita K., Ishioka S., Nishioka Y., Terasawa K., Mori M., et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 67 1 (2004) 33-39
12. Nieminen U., and Soderlin E. Sarcoma of the corpus uteri. Results of the treatment of 117 cases. Strahlentherapie 148 1 (Jul 1974) 57-61
13. Kahanpaa K.V., Wahlstrom T., Grohn P., Heinonen E., Nieminen U., and Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67 3 (Mar 1986) 417-424
14. Gadducci A., Cosio S., Romanini A., and Genazzani A.R. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65 2 (Feb 2008) 129-142
15. Sleijfer S., Seynaeve C., and Verweij J. Gynaecological sarcomas. Curr Opin Oncol 19 5 (Sep 2007) 492-496
16. Giuntoli II R.L., Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89 3 (Jun 2003) 460-469
17. Leitao M.M., Sonoda Y., Brennan M.F., Barakat R.R., and Chi D.S. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 91 1 (Oct 2003) 209-212
18. Goff B.A., Rice L.W., Fleischhacker D., Muntz H.G., Falkenberry S.S., Nikrui N., et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 50 1 (Jul 1993) 105-109
19. Temkin S.M., Hellmann M., Lee Y.C., and Abulafia O. Early-stage carcinosarcoma of the uterus: the significance of lymph node count. Int J Gynecol Cancer 17 1 (Jan-Feb 2007) 215-219
20. Kanjeekal S., Chambers A., Fung M.F., and Verma S. Systemic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 97 2 (May 2005) 624-637
21. Wade K., Quinn M.A., Hammond I., Williams K., and Cauchi M. Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 39 3 (Dec 1990) 364-367
22. Akhan S.E., Yavuz E., Tecer A., Iyibozkurt C.A., Topuz S., Tuzlali S., et al. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study. Gynecol Oncol 99 1 (Oct 2005) 36-42
23. Garrett A., and Quinn M.A. Hormonal therapies and gynaecological cancers. Best Pract Res Clin Obstet Gynaecol (Sep 18 2007)
24. International Federation of Gynecology and Obstetrics. Annual report of the results of treatment in gynaecological cancer. J Epidemiol Biostat (2006) 6
25. Schwartz S.M., Weiss N.S., Daling J.R., Gammon M.D., Liff J.M., Watt J., et al. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer 77 4 (Feb 15 1996) 717-724
26. Arenas M., Rovirosa A., Hernandez V., Ordi J., Jorcano S., Mellado B., et al. Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer 16 2 (Mar-Apr 2006) 861-865
27. Wickerham D.L., Fisher B., Wolmark N., Bryant J., Costantino J., Bernstein L., et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 20 11 (Jun 1 2002) 2758-2760
28. Homesley H., Filiaci V., Markman M., Bitterman P., Eaton L., Kilgore L., et al. Phase III Trial of Ifosfamide with or without paclitaxel in advanced uterine carcinosarcomas: a Gynecologic Oncology Group Study. J Clin Oncol 25 5 (Feb 10 2007) 526-531
29. Wolfson A., Brady M., Rocereto T., Mannel R., Lee Y.C., Futoran R., et al. A gynecologic oncology group randomized trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 107 (Sept 2007) 177-185
30. Koivisto-Korander R., Leminen A., and Heikinheimo O. Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma. Obstet Gynecol 109 2 Pt2 (Feb 2007) 512-514
31. Koide S.S. Mifepristone. Auxiliary therapeutic use in cancer and related disorders. J Reprod Med 43 7 (Jul 1998) 551-560
32. Maluf F.C., Sabbatini P., Schwartz L., Xia J., and Aghajanian C. Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82 2 (Aug 2001) 384-388
33. Leunen M., Breugelmans M., De Sutter P., Bourgain C., and Amy J.J. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 95 3 (Dec 2004) 769-771
34. Wolfson A.H., Wolfson D.J., Sittler S.Y., Breton L., Markoe A.M., Schwade J.G., et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52 1 (Jan 1994) 56-62
35. Kvale G., Heuch I., and Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res 48 21 (Nov 1 1988) 6217-6221
36. Amant F., Cadron I., Fuso L., Berteloot P., de Jonge E., Jacomen G., et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 98 2 (Aug 2005) 274-280
37. Vaidya A.P., Horowitz N.S., Oliva E., Halpern E.F., and Duska L.R. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Gynecol Oncol 103 2 (Nov 2006) 684-687